139 related articles for article (PubMed ID: 1594886)
1. Iopentol in patients with chronic renal failure: its effects on renal function and its use as glomerular filtration rate parameter.
Berg KJ; Kolmannskog F; Lillevold PE; Nordal KP; Ressem L; Rootwelt K; Svaland MG
Scand J Clin Lab Invest; 1992 Feb; 52(1):27-33. PubMed ID: 1594886
[TBL] [Abstract][Full Text] [Related]
2. Effect of iopentol on renal function and its use for calculation of glomerular filtration rate in children.
Stake G; Monclair T; Berg KJ; Rootwelt K; Brekke O
Acta Radiol; 1995 Jan; 36(1):64-8. PubMed ID: 7833171
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of iopentol in patients with chronic renal failure.
Svaland MG; Kolmannskog F; Lillevold PE; Nordal KP; Ressem L; Berg KJ
Acta Radiol; 1992 Sep; 33(5):482-4. PubMed ID: 1389660
[TBL] [Abstract][Full Text] [Related]
4. Renal effects of the non-ionic contrast medium iopentol after intravenous injection in healthy volunteers.
Jakobsen JA; Berg KJ; Waaler A; Andrew E
Acta Radiol; 1990 Jan; 31(1):87-91. PubMed ID: 2187515
[TBL] [Abstract][Full Text] [Related]
5. Renal effects of nonionic contrast media after cardioangiography.
Jakobsen JA; Berg KJ; Brodahl U; Laake B; Moxness A
Acta Radiol; 1994 Mar; 35(2):191-6. PubMed ID: 8172750
[TBL] [Abstract][Full Text] [Related]
6. Renal effects of iopentol and iohexol after intravenous injection.
Jakobsen JA; Kolbenstvedt AN; Berg KJ
Acta Radiol; 1991 Jul; 32(4):320-4. PubMed ID: 1863505
[TBL] [Abstract][Full Text] [Related]
7. Angiography with nonionic X-ray contrast media in severe chronic renal failure: renal function and contrast retention.
Jakobsen JA; Berg KJ; Kjaersgaard P; Kolmannskog F; Nordal KP; Nossen JO; Rootwelt K
Nephron; 1996; 73(4):549-56. PubMed ID: 8856250
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of iopentol in healthy volunteers.
Waaler A; Jørgensen NP; Koksvik B; Skinnemoen K; Andrew E
Acta Radiol Suppl; 1987; 370():113-7. PubMed ID: 2980304
[TBL] [Abstract][Full Text] [Related]
9. Effect of haemodialysis after contrast medium administration in patients with renal insufficiency.
Lehnert T; Keller E; Gondolf K; Schäffner T; Pavenstädt H; Schollmeyer P
Nephrol Dial Transplant; 1998 Feb; 13(2):358-62. PubMed ID: 9509446
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of six radionuclidic and non-radionuclidic methods for the assessment of glomerular filtration rate in patients with chronic renal failure].
Fotopoulos A; Bokharhli JA; Tsiouris S; Katsaraki A; Papadopoulos A; Tsironi M; Theodorou J
Hell J Nucl Med; 2006; 9(2):133-40. PubMed ID: 16894423
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of renal function with delayed CT after injection of nonionic monomeric and dimeric contrast media in healthy volunteers.
Jakobsen JA; Lundby B; Kristoffersen DT; Borch KW; Hald JK; Berg KJ
Radiology; 1992 Feb; 182(2):419-24. PubMed ID: 1732960
[TBL] [Abstract][Full Text] [Related]
12. Nephrotoxicity of ioxaglate and ioversol assessed by glomerular filtration rate: a pilot study.
Millward SF; Burbridge BE; Hartman NG; Moher D; Chamberlain MJ
Can Assoc Radiol J; 1996 Feb; 47(1):24-9. PubMed ID: 8548465
[TBL] [Abstract][Full Text] [Related]
13. Glomerular filtration rate estimated from the uptake phase of 99mTc-DTPA renography in chronic renal failure.
Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
Nephrol Dial Transplant; 1999 Jul; 14(7):1673-8. PubMed ID: 10435875
[TBL] [Abstract][Full Text] [Related]
14. Renal tubular effects of diuretics and X-ray contrast media. A comparative study of equimolar doses in healthy volunteers.
Jakobsen JA; Nossen JO; Jørgensen NP; Berg KJ
Invest Radiol; 1993 Apr; 28(4):319-24. PubMed ID: 8478172
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of Gd-DTPA in patients with chronic renal failure.
Schuhmann-Giampieri G; Krestin G
Invest Radiol; 1991 Nov; 26(11):975-9. PubMed ID: 1743921
[TBL] [Abstract][Full Text] [Related]
16. Renal tolerance of gadolinium-DTPA/dimeglumine in patients with chronic renal failure.
Haustein J; Niendorf HP; Krestin G; Louton T; Schuhmann-Giampieri G; Clauss W; Junge W
Invest Radiol; 1992 Feb; 27(2):153-6. PubMed ID: 1601607
[TBL] [Abstract][Full Text] [Related]
17. Renal tolerance for ioxaglate in patients with chronic renal failure.
Deray G; Cacoub P; Jacquiaud C; Drobinski G; Brillet G; Bunker D; Jaudon MC; Jacobs C
Radiology; 1991 May; 179(2):395-7. PubMed ID: 2014280
[TBL] [Abstract][Full Text] [Related]
18. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
[TBL] [Abstract][Full Text] [Related]
19. Metabolic clearance of recombinant human growth hormone in health and chronic renal failure.
Haffner D; Schaefer F; Girard J; Ritz E; Mehls O
J Clin Invest; 1994 Mar; 93(3):1163-71. PubMed ID: 8132756
[TBL] [Abstract][Full Text] [Related]
20. [Effectiveness of nephroprotection by the selection of contrast media used during vascular interventions in patients with chronic renal failure?].
Schönefeld E; Höwler S; Osada N; Torsello G
Zentralbl Chir; 2011 Oct; 136(5):426-30. PubMed ID: 22009540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
